XML 45 R37.htm IDEA: XBRL DOCUMENT
v3.26.1

Segment Reporting (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2026
Segment Reporting [Abstract] |
Summary of Disaggregated Amounts that Comprise Research and Development and General and Administrative Expenses | In addition to the significant expense categories included within consolidated net income (loss) presented on the Company's condensed consolidated statements of operations and comprehensive income (loss), see below for disaggregated amounts that comprise research and development and general and administrative expenses:
|  | THREE MONTHS ENDED MARCH 31, |
|  | 2026 |  |  | 2025 |
Operating expenses: |  |  |  |  |  |
Research and development: |  |  |  |  |  |
Clinical development |  | $ | 4,834 |  |  | $ | 1,245 |
Employee-related |  |  | 4,118 |  |  |  | 2,152 |
Facility and equipment costs |  |  | 347 |  |  |  | 378 |
Pre-clinical research |  |  | 26 |  |  |  | 117 |
Other research and development segment expenses |  |  | 515 |  |  |  | 124 |
Total research and development |  |  | 9,840 |  |  |  | 4,016 |
General and administrative: |  |  |  |  |  |
Employee-related |  |  | 2,366 |  |  |  | 1,716 |
Professional and consulting fees |  |  | 2,049 |  |  |  | 1,803 |
Commercial readiness |  |  | 1,338 |  |  |  | 131 |
Other general and administrative segment expenses (1) |  |  | 691 |  |  |  | 464 |
Total general and administrative |  |  | 6,444 |  |  |  | 4,114 |
Total operating expenses |  |  | 16,284 |  |  |  | 8,130 |
Loss from operations |  |  | (16,284 | ) |  |  | (8,130 | )
Grant income |  |  | 22 |  |  |  | — |
Interest income |  |  | 1,322 |  |  |  | 934 |
Interest expense |  |  | (1,564 | ) |  |  | (306 | )
Change in fair value of warrant liabilities |  |  | 7,643 |  |  |  | 14,881 |
Net income (loss) |  | $ | (8,861 | ) |  | $ | 7,379 |
(1) Other general and administrative segment expenses primarily consist of insurance, recruiting, occupancy, and information technology costs.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration